In a mice model of melanoma, the β3-AR blockade with intra-tumor injections of SR59230A, the β3-AR antagonist, reduced tumor growth and vasculature through melanoma cells apoptosis, showing, thus, the involvement of β3-ARs in melanoma cell survival and proliferation [15]. This evidence concerns the gene ADRB3 and neoplasm.